Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Trial in Progress: Phase 1/2 Study of Cereblon-Modulating Agent Golcadomide (BMS-986369/CC-99282) in Relapsed or Refractory (R/R) T-Cell Lymphomas (TCLs) (GOLSEEK-3)

Koji Izutsu, Noriko Fukuhara, Makoto Sugaya, Yuichi Baba, Jin Hayakawa, Mitsufumi Nishio, Alev Akyol, Akshay Sudhindra, Kenji Ishitsuka

Blood (2024) 144 (Supplement 1): 3123.3.

https://doi.org/10.1182/blood-2024-203202

Published: 2024

Journal Articles

Oral Azacytidine in Patients with Relapsed/Refractory Angioimmunoblastic T-Cell Lymphoma: Final Analysis of the Oracle Phase III Study

Blood (2022) 140 (Supplement 1): 2310–2312.

https://doi.org/10.1182/blood-2022-156789

Published: 2022

Journal Articles

Addition of Bortezomib to Melphalan Plus Dexamethasone Provides Rapid Response in AL Amyloidosis

Toshiaki Hayashi, MD PhD, Tetsuyuki Igarashi, MD, Hiroshi Ikeda, MD PhD, Mitsufumi Nishio, MD PhD, Tadao Ishida, MD PhD, Yasuhisa Shinomura, MD PhD

Blood (2014) 124 (21): 5766.

https://doi.org/10.1182/blood.V124.21.5766.5766

Published: 2014

Journal Articles

Macrophages Engulf Tumor B Cells Coated With Rituximab More Effectively Under The Hypoxic Condition

Yuri Hata, Mitsufumi Nishio, MD, PhD

Blood (2013) 122 (21): 4711.

https://doi.org/10.1182/blood.V122.21.4711.4711

Published: 2013

Journal Articles

Lymphopenia and an Elevated Monocyte Count At Diagnosis Do Not Predict a Poor Outcome After Autologous Transplants for Diffuse Large B-Cell Lymphoma in the First Remission

Mitsufumi Nishio, MD, PhD, Satoshi Yamamoto, MD, PhD, Tomoyuki Endo, MD, PhD, Katsuya Fujimoto, MD, PhD, Toshiya Sakai, MD, PhD, Takeshi Kondo, MD, PhD, Akio Shigematsu, MD, PhD, Junichi Sugita, MD, PhD, Satoshi Hashino, MD, PhD, Junji Tanaka, M.D., Masahiro Imamura, MD, PhD, Takanori Teshima, MD, PhD

Blood (2012) 120 (21): 4544.

https://doi.org/10.1182/blood.V120.21.4544.4544

Published: 2012

Journal Articles

Molecular and Pathological Analysis of DOCK Family Proteins in Hematopoietic Malignancy

Hiroshi Nishihara, MD., PhD., Lei Wang, PhD., Mitsufumi Nishio, MD, PhD, Tomoyuki Endo, MD, PhD, Katsuya Fujimoto, MD, PhD, Masato Obara, MD, PhD, Shinya Tanaka, MD., PhD.

Blood (2011) 118 (21): 5230.

https://doi.org/10.1182/blood.V118.21.5230.5230

Published: 2011

Journal Articles

Both DOCK180 and DOCK2 Participate in the CXCL12 and CCL19 Dependent Chemotaxis of Human Dendritic Cells Derived From Monocytes Through the Activation of Rac

Hideki Goto, MD, PhD, Mitsufumi Nishio, MD, PhD, Katsuya Fujimoto, MD, PhD, Tomoyuki Endo, MD, PhD, Masato Obara, MD, PhD, Keisuke Yamaguchi, MD, PhD, Yukari Takeda, MD, PhD, Hiroshi Nishihara, MD, PhD, Takao Koike, MD, PhD, Masahiro Imamura, MD, PhD

Blood (2011) 118 (21): 521.

https://doi.org/10.1182/blood.V118.21.521.521

Published: 2011

Journal Articles

FCGR3A-158V/F Polymorphism May Correlate with the Levels of Immunoglobulin in Patients with Non-Hodgkin’s Lymphoma after Rituximab Treatment as An Adjuvant to Autologous Stem Cell Transplantation.

Mitsufumi Nishio, MD, PhD, Tomoyuki Endo, M.D., Ph.D., Katsuya Fujimoto, M.D., Ph.D., Satoshi Yamamoto, M.D., Ph.D., Masato Obara, M.D., Keisuke Yamaguchi, M.D., Yukari Takeda, M.D., Hideki Goto, M.D., Ikumi Kasahara, M.D., Norihiro Sato, M.D., Ph.D., Takao Koike, M.D., Ph.D.

Blood (2008) 112 (11): 3245.

https://doi.org/10.1182/blood.V112.11.3245.3245

Published: 2008

Journal Articles

DOCK180, a New Surrogate Marker to Distinguish CD34 Positive Acute Leukemia Cells from CD34 Positive Normal Hematopoietic Stem/Progenitor Cells.

Mitsufumi Nishio, MD, PhD, Kohki Kumano, M.D., Ph.D., Katsuya Fujimoto, M.D., Ph.D., Tomoyuki Endo, M.D., Ph.D., Satoshi Yamamoto, M.D., Ph.D., Akio Shigematsu, MD, PhD, Takeshi Kondo, MD., PhD, Junji Tanaka, MD, PhD, Satoshi Hashino, Masahiro Imamura, Hiroshi Nishihara, M.D., Ph.D., Norihiro Sato, M.D., Ph.D., Takao Koike, M.D., Ph.D.

Blood (2008) 112 (11): 1476.

https://doi.org/10.1182/blood.V112.11.1476.1476

Published: 2008

Journal Articles

Delayed Redistribution of CD27, CD40 and CD80 Positive B Cells and the Impaired In Vitro Immunoglobulin G Production in Patients with Non-Hodgkin Lymphoma Treated with Rituximab.

Mitsufumi Nishio, MD, PhD, Katsuya Fujimoto, MD, PhD, Satoshi Yamamoto, MD, PhD, Toshiya Sakai, MD, Kohki Kumano, MD, Masato Obara, MD, Kazuki Koizumi, MD, PhD, Masaya Mukai, MD, PhD, Norihiro Sato, MD, PhD, Takao Koike, MD, PhD

Blood (2006) 108 (11): 938.

https://doi.org/10.1182/blood.V108.11.938.938

Published: 2006

Journal Articles

BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-κB pathway

Tomoyuki Endo, Mitsufumi Nishio, Thomas Enzler, Howard B. Cottam, Tetsuya Fukuda, Danelle F. James, Michael Karin, Thomas J. Kipps

Blood (2006) 109 (2): 703–710.

https://doi.org/10.1182/blood-2006-06-027755

Published: 2006

Journal Articles

DOCK180 Is Induced with Differentiation from CD14 Positive Monocytes and It Regulates Phagocytosis in Both Macrophages and Dendritic Cells.

Katsuya Fujimoto, MD, Mitsufumi Nishio, MD, PhD, Hiroshi Nishihara, MD, PhD, Ikumi Sato, Lei Wang, Shinya Tanaka, MD, PhD, Takao Koike, MD, PhD

Blood (2005) 106 (11): 3077.

https://doi.org/10.1182/blood.V106.11.3077.3077

Published: 2005

Journal Articles

BAFF and APRIL Protect CLL B Cells from Apoptosis through Activation of NF-κB Canonical Pathway.

Tomoyuki Endo, MD, PhD, Mitsufumi Nishio, MD, PhD, Tetsuya Fukuda, MD, PhD, Howard B. Cottam, PhD, Susan L. Kalled, PhD, Thomas J. Kipps, MD, PhD

Blood (2005) 106 (11): 179.

https://doi.org/10.1182/blood.V106.11.179.179

Published: 2005

Journal Articles

Absence of an IgD−/CD27+ Switched Memory B Cell Population with Persistent Hypogammaglobulinemia after Rituximab Administration as an Adjuvant Therapy after Autologous Stem Cell Transplantation for Non-Hodgkin Lymphoma.

Mitsufumi Nishio, MD, PhD, Katsuya Fujimoto, MD, Satoshi Yamamoto, MD, PhD, Toshiya Sakai, MD, Masato Obara, MD, Koki Kumano, MD, Koichiro Minauchi, MD, Masayuki Yamakura, MD, Norihiro Sato, MD, PhD, Takao Koike, MD, PhD

Blood (2005) 106 (11): 1412.

https://doi.org/10.1182/blood.V106.11.1412.1412

Published: 2005

Journal Articles

Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1α

Mitsufumi Nishio, Tomoyuki Endo, Nobuhiro Tsukada, Junko Ohata, Shinichi Kitada, John C. Reed, Nathan J. Zvaifler, Thomas J. Kipps

Blood (2005) 106 (3): 1012–1020.

https://doi.org/10.1182/blood-2004-03-0889

Published: 2005

Journal Articles

Nurselike Cells in Chronic Lymphocytic Leukemia (CLL) Express Both BAFF and APRIL that Protect CLL B Cells from Spontaneous Apoptosis by Paracrine Manner.

Mitsufumi Nishio, MD, PhD, Nobuhiro Tsukada, MD, PhD, Junko Ohata, MD, PhD, Nathan J. Zvaifler, MD, Thomas J. Kipps, MD, PhD

Blood (2004) 104 (11): 965.

https://doi.org/10.1182/blood.V104.11.965.965

Published: 2004

Journal Articles

Chronic Lymphocytic Leukemia Cells May Become Less Dependent on Nurse-Like Cells during Later Stages of Disease.

Tomoyuki Endo, MD, PhD, Mitsufumi Nishio, MD, PhD, Laura Rassenti, PhD, Arnon P. Kater, MD, Thomas J. Kipps, MD, PhD

Blood (2004) 104 (11): 4805.

https://doi.org/10.1182/blood.V104.11.4805.4805

Published: 2004

Journal Articles

BAFF Support Survival of Chronic Lymphocytic Leukemia B Cells by a Pathway Independent of Stromal Derived Factor-1α.

Mitsufumi Nishio, MD, PhD, Nobuhiro Tsukada, MD, PhD, Shinichi Kitada, MD, PhD, Junko Ohata, MD, PhD, Nathan J. Zvaifler, MD, John C. Reed, MD, PhD, Thomas J. Kipps, MD, PhD

Blood (2004) 104 (11): 1908.

https://doi.org/10.1182/blood.V104.11.1908.1908

Published: 2004

Journal Articles

Phosphatidylinositol 3-Kinase Is Involved in the Protection of Primary Cultured Human Erythroid Precursor Cells From Apoptosis

Yoshihito Haseyama, Ken-ichi Sawada, Atsushi Oda, Kazuki Koizumi, Hina Takano, Takashi Tarumi, Mitsufumi Nishio, Makoto Handa, Yasuo Ikeda, Takao Koike

Blood (1999) 94 (5): 1568–1577.

https://doi.org/10.1182/blood.V94.5.1568

Published: 1999

NARROW

Trial in Progress: Phase 1/2 Study of Cereblon-Modulating Agent Golcadomide (BMS-986369/CC-99282) in Relapsed or Refractory (R/R) T-Cell Lymphomas (TCLs) (GOLSEEK-3)

Oral Azacytidine in Patients with Relapsed/Refractory Angioimmunoblastic T-Cell Lymphoma: Final Analysis of the Oracle Phase III Study

Addition of Bortezomib to Melphalan Plus Dexamethasone Provides Rapid Response in AL Amyloidosis

Macrophages Engulf Tumor B Cells Coated With Rituximab More Effectively Under The Hypoxic Condition

Lymphopenia and an Elevated Monocyte Count At Diagnosis Do Not Predict a Poor Outcome After Autologous Transplants for Diffuse Large B-Cell Lymphoma in the First Remission

Molecular and Pathological Analysis of DOCK Family Proteins in Hematopoietic Malignancy

Both DOCK180 and DOCK2 Participate in the CXCL12 and CCL19 Dependent Chemotaxis of Human Dendritic Cells Derived From Monocytes Through the Activation of Rac

FCGR3A-158V/F Polymorphism May Correlate with the Levels of Immunoglobulin in Patients with Non-Hodgkin’s Lymphoma after Rituximab Treatment as An Adjuvant to Autologous Stem Cell Transplantation.

DOCK180, a New Surrogate Marker to Distinguish CD34 Positive Acute Leukemia Cells from CD34 Positive Normal Hematopoietic Stem/Progenitor Cells.

Delayed Redistribution of CD27, CD40 and CD80 Positive B Cells and the Impaired In Vitro Immunoglobulin G Production in Patients with Non-Hodgkin Lymphoma Treated with Rituximab.

BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-κB pathway

DOCK180 Is Induced with Differentiation from CD14 Positive Monocytes and It Regulates Phagocytosis in Both Macrophages and Dendritic Cells.

BAFF and APRIL Protect CLL B Cells from Apoptosis through Activation of NF-κB Canonical Pathway.

Absence of an IgD−/CD27+ Switched Memory B Cell Population with Persistent Hypogammaglobulinemia after Rituximab Administration as an Adjuvant Therapy after Autologous Stem Cell Transplantation for Non-Hodgkin Lymphoma.

Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1α

Nurselike Cells in Chronic Lymphocytic Leukemia (CLL) Express Both BAFF and APRIL that Protect CLL B Cells from Spontaneous Apoptosis by Paracrine Manner.

Chronic Lymphocytic Leukemia Cells May Become Less Dependent on Nurse-Like Cells during Later Stages of Disease.

BAFF Support Survival of Chronic Lymphocytic Leukemia B Cells by a Pathway Independent of Stromal Derived Factor-1α.

Phosphatidylinositol 3-Kinase Is Involved in the Protection of Primary Cultured Human Erythroid Precursor Cells From Apoptosis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only